美敦力的新药管局核准的InPen App提供实时胰岛素注射治疗糖尿病。 Medtronic's new FDA-approved InPen app offers real-time insulin dosing for diabetes management.

麦德特龙公司已获得FDA批准,推出了包括Simplera连续血糖监测器在内的Smart MDI系统. Medtronic has received FDA approval for its InPen app, launching the Smart MDI system that includes the Simplera continuous glucose monitor. 这个系统提供实时、个性化的胰岛素剂量建议,包括对误用或不准确剂量的纠正,减少糖尿病管理中的猜测。 This system offers real-time, personalized insulin dosing recommendations, including corrections for missed or inaccurate doses, reducing guesswork in diabetes management. 麦德特龙将首先向现有客户发布该系统,然后再推出. Medtronic will first release the system to existing customers before a broader launch.